RECURRENCE OF A NONSEMINOMATOUS GERM-CELL TUMOR 9 YEARS POSTOPERATIVELY - IS SURVEILLANCE ALONE ACCEPTABLE

被引:4
作者
HURLEY, LJ [1 ]
LIBERTINO, JA [1 ]
机构
[1] LAHEY CLIN FDN,MED CTR,DEPT UROL,BURLINGTON,MA 01805
关键词
TESTICULAR NEOPLASMS; TERATOMA; ORCHIECTOMY;
D O I
10.1016/S0022-5347(01)67641-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report on a patient who underwent left radical orchiectomy for a nonseminomatous germ cell tumor and was placed into a surveillance program only to experience recurrence 9 years later. The deficiencies with surveillance protocols, including inadequate followup, imaging study difficulties, possible higher mortality with relapse of carcinoma during the surveillance period, and increased cost and labor for longer surveillance protocols are discussed. Methods of distinguishing patients at low and high risk of relapse are still evolving and further studies are required.
引用
收藏
页码:1060 / 1062
页数:3
相关论文
共 23 条
[1]   RESULTS OF THE SURVEILLANCE POLICY OF STAGE-I NONSEMINOMATOUS GERM-CELL TESTICULAR-TUMORS [J].
COLLS, BM ;
HARVEY, VJ ;
SKELTON, L ;
THOMPSON, PI ;
DADY, PJ ;
FORGESON, GV ;
PEREZ, DJ .
BRITISH JOURNAL OF UROLOGY, 1992, 70 (04) :423-428
[2]   PROGNOSTIC INDICATORS FOR FAILURE OF SURVEILLANCE MANAGEMENT OF STAGE-I NON-SEMINOMATOUS GERM-CELL TUMORS [J].
COSTELLO, AJ ;
MORTENSEN, PH ;
STILLWELL, RG .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1989, 59 (02) :119-122
[3]   SAFETY OF SURVEILLANCE IN THE MANAGEMENT OF STAGE-1 ANAPLASTIC GERM-CELL TUMORS OF THE TESTIS [J].
CRAWFORD, SM ;
RUSTIN, GJS ;
BEGENT, RHJ ;
NEWLANDS, ES ;
BAGSHAWE, KD .
BRITISH JOURNAL OF UROLOGY, 1988, 61 (03) :250-253
[4]  
DONOHUE JP, 1987, AUA UPDATE SERIES, V6
[5]  
DUNPHY CH, 1988, CANCER, V62, P1202, DOI 10.1002/1097-0142(19880915)62:6<1202::AID-CNCR2820620627>3.0.CO
[6]  
2-S
[7]  
FREEDMAN LS, 1987, LANCET, V2, P294
[8]  
HERR HW, 1990, PROGR CLIN BIOL RES, V5, P295
[9]   PROGNOSTIC FACTORS IN STAGE-I NONSEMINOTAMOUS GERM-CELL TESTICULAR-TUMORS MANAGED BY ORCHIECTOMY AND SURVEILLANCE - IMPLICATIONS FOR ADJUVANT CHEMOTHERAPY [J].
HOSKIN, P ;
DILLY, S ;
EASTON, D ;
HORWICH, A ;
HENDRY, W ;
PECKHAM, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) :1031-1036
[10]   HISTOPATHOLOGICAL FEATURES IN STAGE-I NONSEMINOTAMOUS TESTICULAR GERM-CELL TUMORS CORRELATED TO RELAPSE [J].
JACOBSEN, GK ;
RORTH, M ;
OSTERLIND, K ;
VONDERMAASE, H ;
JACOBSEN, A ;
MADSEN, EL ;
PEDERSEN, M ;
SCHULTZ, H .
APMIS, 1990, 98 (04) :377-382